Literature DB >> 34002583

Gold-based nanomaterials for the treatment of brain cancer.

Li Tu1, Zheng Luo1, Yun-Long Wu1, Shuaidong Huo1, Xing-Jie Liang2.   

Abstract

Brain cancer, also known as intracranial cancer, is one of the most invasive and fatal cancers affecting people of all ages. Despite the great advances in medical technology, improvements in transporting drugs into brain tissue have been limited by the challenge of crossing the blood-brain barrier (BBB). Fortunately, recent endeavors using gold-based nanomaterials (GBNs) have indicated the potential of these materials to cross the BBB. Therefore, GBNs might be an attractive therapeutic strategy against brain cancer. Herein, we aim to present a comprehensive summary of current understanding of the critical effects of the physicochemical properties and surface modifications of GBNs on BBB penetration for applications in brain cancer treatment. Furthermore, the most recent GBNs and their impressive performance in precise bioimaging and efficient inhibition of brain tumors are also summarized, with an emphasis on the mechanism of their effective BBB penetration. Finally, the challenges and future outlook in using GBNs for brain cancer treatment are discussed. We hope that this review will spark researchers' interest in constructing more powerful nanoplatforms for brain disease treatment.
Copyright © 2021 Cancer Biology & Medicine.

Entities:  

Keywords:  BBB penetration; Gold-based; brain cancer therapy; nanomaterials

Year:  2021        PMID: 34002583     DOI: 10.20892/j.issn.2095-3941.2020.0524

Source DB:  PubMed          Journal:  Cancer Biol Med        ISSN: 2095-3941            Impact factor:   4.248


  3 in total

Review 1.  Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment.

Authors:  Lin Tang; Yicheng Feng; Sai Gao; Qingchun Mu; Chaoyong Liu
Journal:  Front Pharmacol       Date:  2021-11-25       Impact factor: 5.810

Review 2.  Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives.

Authors:  Xiande Wang; Cheng Wu; Shiming Liu; Deqing Peng
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Explainability of deep neural networks for MRI analysis of brain tumors.

Authors:  Ramy A Zeineldin; Mohamed E Karar; Ziad Elshaer; Jan Coburger; Christian R Wirtz; Oliver Burgert; Franziska Mathis-Ullrich
Journal:  Int J Comput Assist Radiol Surg       Date:  2022-04-23       Impact factor: 3.421

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.